LICENSED ANTHRAX VACCINES AND EXPERIMENTAL PREPARATIONS AT THE STAGE OF CLINICAL TRIALS
High pathogenicity of anthrax agent combined with unique insensitivity of its spore forms to environmental stresses class it among extremely dangerous biological agents. Registered and effectively used anthrax vaccines made invaluable contribution to the improvement of epidemiological situation arou...
Main Authors: | N. I. Mikshis, P. Yu. Popova, A. P. Semakova, V. V. Kutyrev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Central Research Institute for Epidemiology
2017-08-01
|
Series: | Журнал микробиологии, эпидемиологии и иммунобиологии |
Subjects: | |
Online Access: | https://microbiol.elpub.ru/jour/article/view/186 |
Similar Items
-
Current State of Anthrax Vaccines and Key R&D Gaps Moving Forward
by: Adam Clark, et al.
Published: (2020-04-01) -
COMPLIANCE OF ANTHRAX RECOMBINANT VACCINE PROTOTYPE WITH THE REQUIREMENTS TO IMMUNE-BIOLOGICAL PREPARATIONS
by: N. I. Mikshis, et al.
Published: (2018-11-01) -
Sporadic human cutaneous anthrax outbreak in Shaanxi Province, China: report of two cases from 2018
by: Yuanyuan Liu, et al.
Published: (2020-01-01) -
A putative exosporium lipoprotein GBAA0190 of Bacillus anthracis as a potential anthrax vaccine candidate
by: Jun Ho Jeon, et al.
Published: (2021-03-01) -
Cutaneous Anthrax Patients: Evaluation of Four Family Members
by: Kamil Tünay, et al.
Published: (2016-03-01)